Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SynRinse in Chronic Rhinosinusitis
NCT03154541Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jun 2017
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 2, open-label trial in chronic rhinosinusitis (CRS) (2 cohorts), sponsored by University of Washington. Primary endpoint: Sino-Nasal Outcome Test 22 at 1 week. Started Jun 2017; status: completed.
02
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03154541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03154541.